Drugs Made In America Acquisition Corp.

DMAAR

—

Advanced chart & tools →

Drugs Made In America Acquisition Corp.DMAAR

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.03

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

—

Net income

$5.94M

Net margin

—

Gross margin

—

Dividends & financials

Drugs Made In America Acquisition Corp. (DMAAR) reported revenue of — and net income of $5.94M, or $-0.03 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.